Navigation Links
Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients
Date:12/7/2008

(39%), thrombocytopenia and appetite decreased (including anorexia) (each 36%), pyrexia (34%), vomiting (33%), anemia (29%), edema (23%), headache, paresthesia and dysesthesia and headache (each 22%), dyspnea (21%), cough and insomnia (each 20%), rash (18%), arthralgia (17%), neutropenia and dizziness (excluding vertigo) (each 17%), pain in limb and abdominal pain (each 15%), bone pain (14%), back pain and hypotension (each 13%), herpes zoster, nasopharyngitis, upper respiratory tract infection, myalgia and pneumonia (each 12%), muscle cramps (11%), and dehydration and anxiety (each 10%). Twenty percent (20%) of patients experienced at least 1 episode of greater than or equal to Grade 4 toxicity, most commonly thrombocytopenia (5%) and neutropenia (3%). A total of 50% of patients experienced serious adverse events (SAEs) during the studies. The most commonly reported SAEs included pneumonia (7%), pyrexia (6%), diarrhea (5%), vomiting (4%), and nausea, dehydration, dyspnea and thrombocytopenia (each 3%).

In the Phase 3 VELCADE + melphalan and prednisone study, the safety profile of VELCADE in combination with melphalan/prednisone is consistent with the known safety profiles of both VELCADE and melphalan/prednisone. The most commonly reported adverse events for VELCADE in combination with MP vs MP, respectively, were thrombocytopenia (52% vs 47%), neutropenia (49% vs 46%), nausea (48% vs 28%), peripheral neuropathy (47% vs 5%), diarrhea (46% vs 17%), anemia (43% vs 55%), constipation (37% vs 16%), neuralgia (36% vs 1%), leukopenia (33% vs 30%), vomiting (33% vs 16%), pyrexia (29% vs 19%), fatigue (29% vs 26%), lymphopenia (24% vs 17%), anorexia (23% vs 10%), asthenia (21% vs 18%), cough (21% vs 13%), insomnia (20% vs 13%), edema peripheral (20% vs 10%), rash (19% vs 7%), back pain (17% vs 18%), pneumonia (16% vs 11%), dizziness (16% vs 11%), dyspnea (15% vs 13%), headache (14% vs 10%), pain in extremity (14% vs 9%), abdominal pa
'/>"/>

SOURCE Millennium: The Takeda Oncology Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Novel Technology Breaks Through Cancer Pain
2. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
3. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
4. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
5. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
6. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
9. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
10. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
11. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015 Research and Markets ... of the "Latest Regulations on Pharmaceutical International ... their offering. This is first time ... guidance on international multi-center clinical trials of drugs ... begun to be implemented on March 1, 2015. ...
(Date:5/22/2015)... May 22, 2015 Richmond ... research unit with a worldwide reputation for excellence ... frequent publications in peer reviewed medical journals. Its ... and regulators in discussions about rules for transparency ...      (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , Clinical research ...
(Date:5/21/2015)... , May 21, 2015 ... has announced the addition of the ... (Ankle Replacement, Digit Replacement, Elbow Replacement, Hip ... to 2019" report to their offering. ... knee replacement was valued at $4,470.9 million ...
Breaking Medicine Technology:2015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2North American Joint Reconstruction Market 2015-2019 - Zimmer Holdings, DePuy Synthes Companies, Stryker, Biomet & Smith & Nephew Dominates the $4.4 Billion Market 2
... 2012  Tris Pharma, a technology driven specialty pharmaceutical ... Drug Administration (FDA) has approved the first-ever generic ... dextromethorphan polistirex. Delsym was approved ... generic alternative approved until now. Tris has pioneered ...
... CBI has released their interactive agenda for Access World, ... the annual congresses on Rare Disease, Access Programs for ... Access for shared networking and tailored content. ... regulators during FDA addresses , Case studies from ...
Cached Medicine Technology:Tris Pharma Announces Approval of First-Ever Generic to Delsym® Dextromethorphan Polistirex Extended-Release Suspension 2
(Date:5/22/2015)... Power Systems is proud to announce the sponsorship of ... is in his second year of racing in the professional ... Fire Department in Missoula, MT. He entered the triathlon scene ... career, he has had 15 1st Place finishes. In his ... in all seven of his 2014 races, including two 2nd ...
(Date:5/22/2015)... 22, 2015 According to Berks and ... drug related death, totaling almost 2,500 confirmed drug deaths, as ... state officials, totals 2,489 deaths stemming from legal and illegal ... loses seven people every day to fatal overdoses or other ... out as one of the most rife with drug related ...
(Date:5/22/2015)... York, NY (PRWEB) May 22, 2015 Medivo, ... entitled “Positivity Rates and Genotype Results in ‘Baby Boomers’ ... Results from a Nationwide Lab Test Database” at Digestive Disease ... by Medivo’s Clinical Affairs and Analytics team members Carol Smyth, ... MD; and Andrea Parker, MSI, along with Nancy Reau, MD ...
(Date:5/22/2015)... Wimbledon Health Partners, the leading on-site ... and NCV testing , is proud to announce ... American National athlete, to the Wimbledon Athletics division. ... level of testing and information it provides to be ... trainers, this way they can focus on the task ...
(Date:5/22/2015)... In an effort to support the athletes ... to donate $5 dollars for every maintenance call, and ... softening system. Customers have their needs serviced, and donations ... and the Special Olympics receives money. Hence the name ... 4.4 million athletes, and boasts a myriad of events. ...
Breaking Medicine News(10 mins):Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2Health News:Medivo Study Finds HCV Positivity Rates are 250% Higher Among Baby Boomers 2Health News:Wimbledon Athletics Recruits Team USA Athlete 2Health News:Wimbledon Athletics Recruits Team USA Athlete 3Health News:Parker and Sons is Proud to Support the Special Olympics with Their Everybody Wins Program 2
... findings from the nation,s largest study of diabetes in ... rise among every racial and ethnic group studied. Five ... Care provide a comprehensive picture of diabetes in ... in the United States, including non-Hispanic whites, Hispanics, blacks, ...
... Health Specialists physicians will provide 50 free colonoscopies to patients impacted ... ... (PRWEB) February 27, 2009 -- On Saturday, March 14, the physicians ... to perform 50 free screening colonoscopies to help those in our ...
... Board of Directors of Schering-Plough Corporation (NYSE: SGP ... common share. Payment will be made on May 26, ... on May 1, 2009. As of Jan. 31, 2009, ... today also declared a quarterly dividend of $3.75 per share ...
... looks forward to working with Obama AdministrationWASHINGTON, Feb. 27 ... learn that budget documents released by the White House ... of hospitals owned and operated by reform-minded physicians."We understand ... past CBO data. We look forward to the opportunity ...
... Georgia study suggests that health agencies investigating Salmonella illnesses ... of contamination. , Researchers, whose results appear in the ... Microbiology , tested water over a one-year period in ... known for its high rate of sporadic salmonella cases. ...
... - Probiotics expert Dr. Mary Ellen Sanders and food ... with insightful tips for retailers -TORRANCE, Calif., Feb. 27 ... probiotic products have been introduced to the U.S. marketplace. ... well-informed about what differentiates probiotic products from others is ...
Cached Medicine News:Health News:Many faces of diabetes in American youth: The SEARCH for diabetes in youth study 2Health News:Many faces of diabetes in American youth: The SEARCH for diabetes in youth study 3Health News:Many faces of diabetes in American youth: The SEARCH for diabetes in youth study 4Health News:Local Gastroenterology Practice Gives Back to the Community During Colon Cancer Awareness Month 2Health News:Physician's Hospitals Are a Model of True Health Care Reform 2Health News:Physician's Hospitals Are a Model of True Health Care Reform 3Health News:Physician's Hospitals Are a Model of True Health Care Reform 4Health News:Physician's Hospitals Are a Model of True Health Care Reform 5Health News:Physician's Hospitals Are a Model of True Health Care Reform 6Health News:Physician's Hospitals Are a Model of True Health Care Reform 7Health News:Physician's Hospitals Are a Model of True Health Care Reform 8Health News:Physician's Hospitals Are a Model of True Health Care Reform 9Health News:Physician's Hospitals Are a Model of True Health Care Reform 10Health News:Study suggests surface water contaminated with salmonella more common than thought 2Health News:Study suggests surface water contaminated with salmonella more common than thought 3Health News:Retailers, Buyers to Learn how to Navigate Probiotic Marketplace at Natural Products Expo West 2009 2
Maddox Rod, short handle (12cm)...
Graham Field 10' Reversed Snellen Eye Chart....
... PacScan 300AP is a portable, ... provides easy-to-use touch screen operation. ... frequency, low noise probes and ... capture immediately upon application of ...
Precision that fits in the palm of your hand and measures down to 125 microns, the Pocket Pachymeter is about 8" X 4" x 2" and really does fit in a lab coat pocket or briefcase....
Medicine Products: